Elinton Adami Chaim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Elinton Adami Chaim has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Everton Cazzo
State University of Campinas, Campinas, Brazil
6 shared publications - Felipe David Mendonça Chaim
Universidade Estadual de Campinas, Brasil
5 shared publications - Martinho Antonio Gestic
Universidade Estadual de Campinas (UNICAMP), Brasil
5 shared publications - Murillo Pimentel Utrini
Universidade Estadual de Campinas (UNICAMP), Brasil
5 shared publications - Francisco Callejas-Neto
Universidade Estadual de Campinas (UNICAMP), Brasil
4 shared publications - Almino Cardoso Ramos
Gastro-Obeso-Center
3 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 142 (5) , e2023161
Effects of bariatric surgery on renal function: a retrospective cohort study comparing one-year outcomes between one-anastomosis gastric bypass and Roux-en-Y gastric bypass
Evidence on the effect of one-anastomosis gastric bypass (OAGB) on renal function is limited.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 142 (5) , e2023161
Open AccessEffects of bariatric surgery on renal function: a retrospective cohort study comparing one-year outcomes between one-anastomosis gastric bypass and Roux-en-Y gastric bypass
Evidence on the effect of one-anastomosis gastric bypass (OAGB) on renal function is limited.
- Open Access
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 60 (2) , 241-246
WEIGHT LOSS AND QUALITY OF LIFE AFTER ONE ANASTOMOSIS GASTRIC BYPASS: A 2-YEAR FOLLOW-UP STUDY
Background: Studies assessing quality of life (QoL) after one anastomosis gastric bypass (OAGB) are currently scarce. Objective: To analyze the main weight loss outcomes and QoL in individuals undergoing OAGB during a 2-year follow-up. Methods: This is a retrospective study based on a prospectively collected database including individuals which underwent OAGB at a tertiary-level university hospital. After 2-years, excess weight loss was assessed, and post-surgical therapeutical success was determined using Reinhold’s criteria. QoL was assessed through the Bariatric Analysis and Reporting Outcomes System (BAROS). Results: Out of 41 participants, 90.2% were female and the average age was 38±8.3 years old. The average body mass index significantly decreased from 37.1±5.6 kg/m2 to 27±4.5 kg/m2 after 2-years (P< 0.001). The mean percentage of excess weight loss was 84.6±32.5%. Regarding weight loss outcomes, 61% were considered “excellent”, while 26.8% were “good” according to Reinhold’s criteria. With regards to QoL assessed by BAROS, most individuals achieved a score classified as either “excellent” (26.8%), “very good” (36.6%), or “good” (31.7%). The highest degrees of satisfaction achieved were in the domains “self-esteem” and “work capacity”, in which 75.6% and 61%, respectively, were classified as “much better”. Conclusion: OAGB associated with significant weight loss and resolution of obesity-related medical conditions, as well as relevant QoL improvement assessed by the BAROS system.
- 1 June 2023
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 60 (2) , 241-246
Open AccessWEIGHT LOSS AND QUALITY OF LIFE AFTER ONE ANASTOMOSIS GASTRIC BYPASS: A 2-YEAR FOLLOW-UP STUDY
Background: Studies assessing quality of life (QoL) after one anastomosis gastric bypass (OAGB) are currently scarce. Objective: To analyze the main weight loss outcomes and QoL in individuals undergoing OAGB during a 2-year follow-up. Methods: This is a retrospective study based on a prospectively collected database including individuals which underwent OAGB at a tertiary-level university hospital. After 2-years, excess weight loss was assessed, and post-surgical therapeutical success was determined using Reinhold’s criteria. QoL was assessed through the Bariatric Analysis and Reporting Outcomes System (BAROS). Results: Out of 41 participants, 90.2% were female and the average age was 38±8.3 years old. The average body mass index significantly decreased from 37.1±5.6 kg/m2 to 27±4.5 kg/m2 after 2-years (P< 0.001). The mean percentage of excess weight loss was 84.6±32.5%. Regarding weight loss outcomes, 61% were considered “excellent”, while 26.8% were “good” according to Reinhold’s criteria. With regards to QoL assessed by BAROS, most individuals achieved a score classified as either “excellent” (26.8%), “very good” (36.6%), or “good” (31.7%). The highest degrees of satisfaction achieved were in the domains “self-esteem” and “work capacity”, in which 75.6% and 61%, respectively, were classified as “much better”. Conclusion: OAGB associated with significant weight loss and resolution of obesity-related medical conditions, as well as relevant QoL improvement assessed by the BAROS system.
- Open Access
- 12 September 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (6) , 739-746
Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study
BACKGROUND: The long-term effects of bariatric surgery on the course of non-alcoholic fatty hepatopa-thy (NAFLD) are not fully understood.OBJECTIVE: To analyze the evolution of NAFLD characteristics through noninvasive markers after Roux-en-Y gastric bypass (RYGB) over a five-year period.DESIGN AND SETTING: Historical cohort study; tertiary-level university hospital.METHODS: The evolution of NAFLD-related characteristics was evaluated among 49 individuals who un-derwent RYGB, with a five-year follow-up. Steatosis was evaluated through the hepatic steatosis index (HSI), steatohepatitis through the clinical score for non-alcoholic steatohepatitis (C-NASH) and fibrosis through the NAFLD fibrosis score (NFS).RESULTS: 91.8% of the individuals were female. The mean age was 38.3 +/- 10 years and average body mass index (BMI), 37.4 +/- 2.3 kg/m2. HSI significantly decreased from 47.15 +/- 4.27 to 36.03 +/- 3.72 at 12 months (P < 0.01), without other significant changes up to 60 months. C-NASH significantly decreased from 0.75 +/- 1.25 to 0.29 +/- 0.7 at 12 months (P < 0.01), without other significant changes up to 60 months. NFS de-creased from 1.14 +/- 1.23 to 0.27 +/- 0.99 at 12 months (P < 0.01), and then followed a slightly ascending course, with a marked increase by 60 months (0.82 +/- 0.89), but still lower than at baseline (P < 0.05). HSI variation strongly correlated with the five-year percentage total weight loss (R = 0.8; P < 0.0001).CONCLUSION: RYGB led to significant improvement of steatosis, steatohepatitis and fibrosis after five years. Fibrosis was the most refractory abnormality, with a slightly ascending trend after two years. Steato-sis improvement directly correlated with weight loss.
- 12 September 2022
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (6) , 739-746
Open AccessTrajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study
BACKGROUND: The long-term effects of bariatric surgery on the course of non-alcoholic fatty hepatopa-thy (NAFLD) are not fully understood.OBJECTIVE: To analyze the evolution of NAFLD characteristics through noninvasive markers after Roux-en-Y gastric bypass (RYGB) over a five-year period.DESIGN AND SETTING: Historical cohort study; tertiary-level university hospital.METHODS: The evolution of NAFLD-related characteristics was evaluated among 49 individuals who un-derwent RYGB, with a five-year follow-up. Steatosis was evaluated through the hepatic steatosis index (HSI), steatohepatitis through the clinical score for non-alcoholic steatohepatitis (C-NASH) and fibrosis through the NAFLD fibrosis score (NFS).RESULTS: 91.8% of the individuals were female. The mean age was 38.3 +/- 10 years and average body mass index (BMI), 37.4 +/- 2.3 kg/m2. HSI significantly decreased from 47.15 +/- 4.27 to 36.03 +/- 3.72 at 12 months (P < 0.01), without other significant changes up to 60 months. C-NASH significantly decreased from 0.75 +/- 1.25 to 0.29 +/- 0.7 at 12 months (P < 0.01), without other significant changes up to 60 months. NFS de-creased from 1.14 +/- 1.23 to 0.27 +/- 0.99 at 12 months (P < 0.01), and then followed a slightly ascending course, with a marked increase by 60 months (0.82 +/- 0.89), but still lower than at baseline (P < 0.05). HSI variation strongly correlated with the five-year percentage total weight loss (R = 0.8; P < 0.0001).CONCLUSION: RYGB led to significant improvement of steatosis, steatohepatitis and fibrosis after five years. Fibrosis was the most refractory abnormality, with a slightly ascending trend after two years. Steato-sis improvement directly correlated with weight loss.
- Open Access
- 19 July 2022
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 26 (4) , 325-332
Relationships of hepatic histopathological findings and bile microbiological aspects with bile duct injury repair surgical outcomes: A historical cohort
Guilherme Hoverter Callejas, Rodolfo Araujo Marques, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Elinton Adami Chaim, Francisco Callejas-Neto, Everton Cazzo. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.22-003
- 19 July 2022
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Annals of Hepato-Biliary-Pancreatic Surgery
- Vol. 26 (4) , 325-332
Open AccessRelationships of hepatic histopathological findings and bile microbiological aspects with bile duct injury repair surgical outcomes: A historical cohort
Guilherme Hoverter Callejas, Rodolfo Araujo Marques, Martinho Antonio Gestic, Murillo Pimentel Utrini, Felipe David Mendonça Chaim, Elinton Adami Chaim, Francisco Callejas-Neto, Everton Cazzo. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.22-003
- Open Access
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 59 (1) , 110-116
SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS
Background Non-invasive markers are useful and practical tools for assessing non-alcoholic fatty liver disease (NAFLD), but liver biopsy remains the gold-standard method. Liver biopsy can be easily obtained on individuals undergoing bariatric surgery, but there is no ultimate evidence on the relationship between costs, risks and benefits of its systematic performance. Objective To compare the diagnostic accuracy of non-invasive methods with liver biopsy for detection and staging of NAFLD in obese individuals undergoing bariatric surgery. Methods This is a cross-sectional, observational and descriptive study which enrolled individuals who underwent bariatric surgery from 2018 through 2019 at a public tertiary university hospital. Ultrasound scan, hepatic steatosis index, Clinical Non-Alcoholic Steatohepatitis Score (C-NASH), hypertension, alanine aminotransferase (ALT) and insulin resistance (HAIR), aspartate aminotransferase (AST) to Platelet Ratio Index (APRI), NAFLD Fibrosis Score (NFS) and body mass index, AST/ALT ratio, and diabetes (BARD) were the methods compared with the histopathological examination of wedge liver biopsies collected during surgery. Results Of 104 individuals analyzed, 91 (87.5%) were female. The mean age was 34.9±9.7 years. There was no biopsy-related morbidity. The respective overall accuracies of each marker analyzed were: ultrasound scan (79.81% for steatosis), hepatic steatosis index (79.81% for steatosis), HAIR (40.23% for steatohepatitis), C-NASH (22.99% for steatohepatitis), APRI (94.23% for advanced fibrosis), NFS (94.23% for advanced fibrosis), and BARD (16.35% for advanced fibrosis). Discussion Given the high prevalence of liver disease within this population, even the most accurate markers did not present enough discretionary power to detect and/or rule out the NAFLD aspects they were designed to assess in comparison with liver biopsy, which is safe and easy to obtain in these patients. Conclusion Wedge liver biopsy during bariatric surgery helps to diagnose and stage NAFLD, presents low risks and acceptable costs; given the limitations of non-invasive methods, it is justifiable and should be considered in bariatric routine.
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 59 (1) , 110-116
Open AccessSHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS
Background Non-invasive markers are useful and practical tools for assessing non-alcoholic fatty liver disease (NAFLD), but liver biopsy remains the gold-standard method. Liver biopsy can be easily obtained on individuals undergoing bariatric surgery, but there is no ultimate evidence on the relationship between costs, risks and benefits of its systematic performance. Objective To compare the diagnostic accuracy of non-invasive methods with liver biopsy for detection and staging of NAFLD in obese individuals undergoing bariatric surgery. Methods This is a cross-sectional, observational and descriptive study which enrolled individuals who underwent bariatric surgery from 2018 through 2019 at a public tertiary university hospital. Ultrasound scan, hepatic steatosis index, Clinical Non-Alcoholic Steatohepatitis Score (C-NASH), hypertension, alanine aminotransferase (ALT) and insulin resistance (HAIR), aspartate aminotransferase (AST) to Platelet Ratio Index (APRI), NAFLD Fibrosis Score (NFS) and body mass index, AST/ALT ratio, and diabetes (BARD) were the methods compared with the histopathological examination of wedge liver biopsies collected during surgery. Results Of 104 individuals analyzed, 91 (87.5%) were female. The mean age was 34.9±9.7 years. There was no biopsy-related morbidity. The respective overall accuracies of each marker analyzed were: ultrasound scan (79.81% for steatosis), hepatic steatosis index (79.81% for steatosis), HAIR (40.23% for steatohepatitis), C-NASH (22.99% for steatohepatitis), APRI (94.23% for advanced fibrosis), NFS (94.23% for advanced fibrosis), and BARD (16.35% for advanced fibrosis). Discussion Given the high prevalence of liver disease within this population, even the most accurate markers did not present enough discretionary power to detect and/or rule out the NAFLD aspects they were designed to assess in comparison with liver biopsy, which is safe and easy to obtain in these patients. Conclusion Wedge liver biopsy during bariatric surgery helps to diagnose and stage NAFLD, presents low risks and acceptable costs; given the limitations of non-invasive methods, it is justifiable and should be considered in bariatric routine.
- Open Access
- 11 June 2021
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 139 (4) , 351-363
Effect of transient obstructive cholestasis on liver histology: a cross-sectional study
The role of transient obstructive cholestasis on liver histology remains undetermined. To investigate whether transient cholestasis impairs liver histology. Cross-sectional study at a public university hospital (UNICAMP), Brazil. 169 individuals undergoing cholecystectomy, with or without cholestasis. were enrolled. Histopathological findings were correlated with clinical and biochemical characteristics. Biliary hepatopathy was more frequent in individuals with resolved cholestasis than in those with active obstruction or no jaundice (P < 0.01), as also were fibrosis and ductular proliferation (P = 0.02). Cholestasis was commoner in individuals with resolved obstruction than in those with no history (P < 0.01) or active cholestasis (P < 0.05). Biliary hepatopathy was associated with longer duration of cholestasis (P < 0.001) and higher bilirubin levels (P = 0.02) in individuals with active obstruction; with lower body mass index (P = 0.02) and longer cholestasis (P < 0.001) in individuals with resolved obstruction; and with longer cholestasis (P < 0.001) and longer interval between endoscopic retrograde cholangiopancreatography and surgery (P = 0.03) overall. In individuals with active obstruction, duration of cholestasis (R = 0.7; P < 0.001) and bilirubin levels (R = 0.6; P = 0.004) were independently correlated with cholestasis severity. Duration of cholestasis (R = 0.7; P < 0.001) was independently correlated with ductular proliferation severity. Transient cholestasis was associated with significant histopathological changes, even after its resolution. Longer duration of obstruction correlated with greater severity of histopathological changes, especially cholestasis and ductular proliferation. This emphasizes the need for early treatment of obstructive cholestasis.
- 11 June 2021
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 139 (4) , 351-363
Open AccessEffect of transient obstructive cholestasis on liver histology: a cross-sectional study
The role of transient obstructive cholestasis on liver histology remains undetermined. To investigate whether transient cholestasis impairs liver histology. Cross-sectional study at a public university hospital (UNICAMP), Brazil. 169 individuals undergoing cholecystectomy, with or without cholestasis. were enrolled. Histopathological findings were correlated with clinical and biochemical characteristics. Biliary hepatopathy was more frequent in individuals with resolved cholestasis than in those with active obstruction or no jaundice (P < 0.01), as also were fibrosis and ductular proliferation (P = 0.02). Cholestasis was commoner in individuals with resolved obstruction than in those with no history (P < 0.01) or active cholestasis (P < 0.05). Biliary hepatopathy was associated with longer duration of cholestasis (P < 0.001) and higher bilirubin levels (P = 0.02) in individuals with active obstruction; with lower body mass index (P = 0.02) and longer cholestasis (P < 0.001) in individuals with resolved obstruction; and with longer cholestasis (P < 0.001) and longer interval between endoscopic retrograde cholangiopancreatography and surgery (P = 0.03) overall. In individuals with active obstruction, duration of cholestasis (R = 0.7; P < 0.001) and bilirubin levels (R = 0.6; P = 0.004) were independently correlated with cholestasis severity. Duration of cholestasis (R = 0.7; P < 0.001) was independently correlated with ductular proliferation severity. Transient cholestasis was associated with significant histopathological changes, even after its resolution. Longer duration of obstruction correlated with greater severity of histopathological changes, especially cholestasis and ductular proliferation. This emphasizes the need for early treatment of obstructive cholestasis.